Page 1 of Clinical Trials for Chugai Pharma USA [SPONSOR-COLLABORATORS], 5 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.
Last Updated: June 23, 2005
Condition(s): Graft Occlusion, Vascular; Coronary Restenosis; Atherosclerosis
2
Completed
An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
Last Updated: June 23, 2005
Condition(s): Breast Neoplasms; Breast Cancer; Metastasis
3
Completed
Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis
Last Updated: June 23, 2005
Condition(s): Gastroparesis
4
Terminated
Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
Last Updated: August 10, 2009
Condition(s): Non Small Cell Lung Cancer
5
Recruiting
Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia
Last Updated: March 23, 2012
Condition(s): Acute Myeloid Leukemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Chugai+Pharma+USA

Page 1 of Clinical Trials for Chugai Pharma USA [SPONSOR-COLLABORATORS], 5 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About